Milestone Pharmaceuticals (MIST) EBT Growth (1y) (2019 - 2022)
Milestone Pharmaceuticals (MIST) EBT Growth (1y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 153.84 Mn | -30.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -5.66% |
| Jun 30, 2022 | -2,282.60% |
| Dec 31, 2021 | -94.83% |
| Sep 30, 2021 | -18.58% |
| Jun 30, 2021 | 105.93% |
| Mar 31, 2021 | 23.43% |
| Dec 31, 2020 | 52.62% |
| Sep 30, 2020 | 7.04% |
| Jun 30, 2020 | 5.00% |
| Mar 31, 2020 | -56.69% |
| Dec 31, 2019 | -89.31% |
| Sep 30, 2019 | -126.39% |
| Jun 30, 2019 | -280.88% |
| Mar 31, 2019 | -150.42% |